William Garner photo

William J. Garner, MD MPH

Managing Director

William (Bill) Garner is a physician, investor and entrepreneur.

Through EGB Ventures, Dr. Garner has founded & financed numerous companies that are now publicly traded on the ASX, CSE, TSX and NASDAQ.

Previously, Dr. Garner worked in medical affairs at Hoffmann LaRoche in oncology. Prior to Roche, Dr. Garner was a merchant banker in New York City.

Dr. Garner has a Master of Public Health from Harvard T.H. Chan School of Public Health and received his M.D. from New York Medical College. Dr. Garner did residency training in Anatomic Pathology at Columbia-Presbyterian and is currently a licensed physician in the State of New York.

Among awards and honors, Dr. Garner was an AMA/Glaxo Wellcome Leadership Award recipient. Some of Dr. Garner’s research was funded by the American Federation for Aging Research. He is an inventor on a wide range of patents.

Daren Graham photo

Daren Graham, JD

Chief Operating Officer

Mr. Graham has 18 years of experience in the life science industry as a merchant banker, senior operations executive, and corporate finance attorney. Prior to joining EGB Ventures, he was a Co-Founder of Osteon Therapeutics, a biopharmaceutical company focused on bone and joint health.

Prior to co-founding Osteon, Mr. Graham was a Managing Director of Allele Capital Partners, a boutique merchant bank focused on funding private and public life sciences companies. During this time, he also served as an Executive Director in Tribal Capital Markets’ Equity Capital Life Sciences Division. Mr. Graham’s responsibilities at Allele and Tribal Capital included sourcing and conducting due diligence on investment opportunities, working to expand Allele’s base of investing partners, structuring debt and equity investment products, and advising companies on their capital market strategies.

Previously, Mr. Graham was Chief Legal Officer and Vice President of Strategic Development at Sancilio Pharmaceuticals Company, Inc., a fully-integrated life sciences company engaged in proprietary and contract research and development, manufacture and distribution of prescription and over-the-counter drug products, including highly-specialized soft gelatin dosage formulations. In addition to acting as Chief Legal Officer, he held responsibility for numerous departments during various stages of the company’s growth, including Accounting & Finance and Quality Assurance.

Mr. Graham began his career in the life science industry as a corporate finance attorney in the Boston headquarters of Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo PC, representing both private and public companies in venture capital financings, public offerings, and ’34 Act compliance. In 2009 he was named to the New England Rising Stars list of outstanding lawyers.

After receiving a BBA in Finance from Northeastern State University of Oklahoma, Mr. Graham earned his Juris Doctorate from Boston College Law School. He is a member of the Massachusetts Bar and holds FINRA Series 7, 63 and 79 licenses (each currently inactive).

Mr. Graham is a Citizen of the Cherokee Nation.